
Regulatory14 Aug 2026, 07:03 pm
Gujarat Kidney: No IPO Fund Deviation as of June 30, 2026
AI Summary
Gujarat Kidney and Super Speciality Ltd confirms no deviation or variation in the utilization of IPO proceeds as of June 30, 2026. The statement, reviewed by the Audit Committee, aligns with the objects stated in the prospectus dated December 24, 2025. Funds were raised on December 24, 2025, and the report covers the first quarter and three months ending June 30, 2026. The company's proposed uses included acquisition of Parekh Hospital, part-payment for Ashwini Medical Centre, development of a multi-speciality hospital, and repayment of secured borrowings. Shareholder approval for variations was obtained on April 25, 2026, via a special resolution.
Key Highlights
- No deviation in IPO fund utilization as of June 30, 2026.
- Statement reviewed by Audit Committee and approved by shareholders.
- Funds earmarked for hospital acquisition and development.
- Repayment of secured borrowings also a stated use of funds.
Price Impact
More from GKSL